From: Should bioprostheses be considered the valve of choice for dialysis-dependent patients?
Variable | Group B (n = 38) | Group M(n = 35) | P-value |
---|---|---|---|
Clinical demographics | |||
Age (y) | 55 ± 8 | 53 ± 9 | NS |
Female sex | 16 (42.1%) | 15(42.9%) | NS |
Mean body mass index (kg/m2) | 24 ± 5 | 26 ± 6 | NS |
Risk factors | |||
Hypertension | 34(89.5%) | 32(91.4%) | NS |
Diabetes | 15(39.5%) | 12(34.3%) | NS |
Obstructive pulmonary disease | 4(10.5%) | 3(8.6%) | NS |
Previous gastrointestinal bleed | 7(18.4%) | 6(17.1%) | NS |
Peripheral vascular disease | 3(7.9%) | 2(5.7%) | NS |
Mean preoperative creatinine (mg/dl) | 4.5 ± 1.2 | 4.8 ± 1.4 | NS |
Cardiac profile | |||
Previous myocardial infarction | 2(5.3%) | 2(5.7%) | NS |
Previous PCI | 5(13.2%) | 4(11.4%) | NS |
Cardiac arrhythmia | 27(71.1%) | 31(88.6%) | <0.05 |
Congestive heart failure (NYHA III-IV) | 12(31.6%) | 11(31.4%) | NS |
Mean ejection fraction | 0.50 ± 0.12 | 0.49 ± 0.14 | NS |
Poor ejection fraction (<0.35) | 4(10.5%) | 4(11.4%) | NS |
Preoperative endocarditis | 6(15.8%) | 5(14.3%) | NS |
Mean EuroSCORE (%) | 32 ± 23 | 31 ± 22 | NS |